IntelliPharmaCeutics Intl


Company Update (NASDAQ:IPCI): IntelliPharmaCeutics Intl Inc (USA) Announces Third Quarter 2016 Results

IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI) reported the results of operations for the three and nine months ended August 31, 2016.  All dollar amounts referenced …

Brean Capital Comments On Intellipharmaceutics Following Licensing Agreement With Teva

Brean Capital analyst Jonathan Aschoff came out today with a research note on Intellipharmaceutics (NASDAQ:IPCI), as the company announced a licensing agreement with Teva …

Maxim Maintains Buy On Intellipharmaceutics Following License Agreement With Teva

Maxim’s healthcare analyst Jason Kolbert is weighing in with an update on Intellipharmaceutics International (NASDAQ:IPCI), as the company announced the it has signed a license agreement …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts